[Pituitary-adrenocortical function of women following Gestagen administration].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000311:Adrenal Glands / Q000187:drug effects*; D000324:Adrenocorticotropic Hormone; D000328:Adult; D003276:Contraceptives, Oral / Q000494:pharmacology*; D003907:Dexamethasone; D005260:Female; D005938:Glucocorticoids / Q000097:blood; D006801:Humans; D008535:Megestrol / Q000494:pharmacology; D008656:Mestranol / Q000494:pharmacology*; D008797:Metyrapone; D009640:Norethindrone / Q000494:pharmacology*; D010901:Pituitary Function Tests; D010902:Pituitary Gland / Q000187:drug effects*; D010912:Pituitary-Adrenal Function Tests; D010913:Pituitary-Adrenal System / Q000187:drug effects; D011247:Pregnancy; D011555:Pseudopregnancy / Q000188:drug therapy*; D013256:Steroids / Q000652:urine; D013739:Testosterone
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D003276:Contraceptives, Oral; D005938:Glucocorticoids; D013256:Steroids; D013739:Testosterone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D008656:Mestranol; D008535:Megestrol; D009640:Norethindrone; D008797:Metyrapone